Schubert & Co’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-54
Closed -$3.66K 531
2023
Q1
$3.66K Buy
54
+8
+17% +$514 ﹤0.01% 607
2022
Q4
$2.28K Buy
46
+38
+475% +$1.55K ﹤0.01% 802
2022
Q3
$0 Sell
8
-16
-67% -$660 ﹤0.01% 1434
2022
Q2
$1K Buy
24
+18
+300% +$963 ﹤0.01% 1075
2022
Q1
$0 Hold
6
﹤0.01% 1151
2021
Q4
$0 Buy
+6
New +$530 ﹤0.01% 1085

Other funds holding EXAS

Schubert & Co's EXAS Position: Q2 2023 in Review

Schubert & Co sold out of Exact Sciences (EXAS) in Q2 2023, closing a stake of 54 shares — an estimated $3.66K sold.

Schubert & Co first reported a position in EXAS in Q4 2021 and held it in 6 quarters. The position peaked at $3.66K in Q1 2023. 654 funds tracked by Wall St. Rank hold EXAS as of Q2 2023.

  • Schubert & Co reported no remaining Exact Sciences position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 54 Exact Sciences shares in Q2 2023, an estimated $3.66K.
  • Schubert & Co first reported a position in Exact Sciences in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's Exact Sciences position peaked at $3.66K in Q1 2023.
  • 654 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.